TWD 175.0
(-1.41%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 239.78 Million | 338.67 Million | 21.72 Million | 65.68 Million | - |
Net Income | 162.21 Million | 332.21 Million | 134.45 Million | 106.12 Million | - |
Depreciation & Amortization | 55.13 Million | 42.22 Million | 34.74 Million | 31.12 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 23 Million | - | - | - | - |
Change in working capital | 88.63 Million | -5.56 Million | -125.25 Million | -49.67 Million | - |
Other non-cash items | 1.71 Million | 5.34 Million | 4.28 Million | 4.96 Million | - |
Investing Cash Flow | -843.89 Million | -267.83 Million | -217.5 Million | -115.14 Million | - |
Investments in PPE | -256.29 Million | -265.28 Million | -216.11 Million | -113.49 Million | - |
Acquisitions | 5000.00 | - | - | - | - |
Investment purchases | -65.5 Million | -2.6 Million | - | -1.8 Million | - |
Sales/Maturities of investments | - | - | 200 Thousand | - | - |
Other Investing Activities | -522.1 Million | 25 Thousand | -1.58 Million | - | 562 Thousand |
Financing Cash Flow | 504.42 Million | 85.91 Million | 325.29 Million | 82.95 Million | - |
Debt repayment | -116.26 Million | -236.69 Million | -228.42 Million | -88.61 Million | - |
Dividends payments | -166.17 Million | -60.94 Million | -24.99 Million | -592 Thousand | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 557.6 Million | 385.67 Million | 123.6 Million | - | - |
Other Financing Activities | -3.27 Million | - | - | -3.34 Million | - |
Accounts receivables | 35.07 Million | - | - | - | - |
Accounts payables | -11.52 Million | - | - | - | - |
Inventory | 49.42 Million | -71.82 Million | -59.24 Million | -12.01 Million | - |
Other working capital | 4.13 Million | - | - | - | - |
Cash at beginning of period | 421.91 Million | 264.34 Million | 135.13 Million | 100.86 Million | - |
Cash at end of period | 320.53 Million | 421.91 Million | 264.34 Million | 135.13 Million | - |
Capital Expenditure | -256.29 Million | -265.28 Million | -216.11 Million | -113.49 Million | - |
Effect of forex changes on cash | -1.68 Million | 827 Thousand | -315 Thousand | 785 Thousand | - |
Net cash flow / Change in cash | -101.38 Million | 157.57 Million | 129.2 Million | 34.27 Million | - |
Free Cash Flow | -16.5 Million | 73.38 Million | -194.38 Million | -47.81 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 48.01 Million | 52.42 Million | 162.21 Million | 19.92 Million | 29.36 Million | 50.02 Million |
Depreciation & Amortization | 20.4 Million | 18.8 Million | 55.13 Million | 15 Million | 14.12 Million | 13.44 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 23 Million | - | - | - |
Change in working capital | 6.14 Million | 12.43 Million | 88.63 Million | 11.44 Million | -36.94 Million | -9.71 Million |
Other non-cash items | 510 Thousand | 1.26 Million | 1.71 Million | 851 Thousand | 972 Thousand | -123 Thousand |
Investing Cash Flow | -113.02 Million | -15.11 Million | -843.89 Million | -391.89 Million | -174.94 Million | -170.76 Million |
Investments in PPE | -113.11 Million | -81.05 Million | -256.29 Million | -58.64 Million | -54.91 Million | -30.86 Million |
Acquisitions | - | - | 5000.00 | - | - | - |
Investment purchases | - | - | -65.5 Million | - | - | - |
Sales/Maturities of investments | - | 66.7 Million | - | - | - | - |
Other Investing Activities | 88 Thousand | -760 Thousand | -522.1 Million | -262.04 Million | -120.02 Million | -139.9 Million |
Financing Cash Flow | -4 Million | -3.61 Million | 504.42 Million | 296.48 Million | 202.83 Million | 89.2 Million |
Debt repayment | -2.11 Million | -2.11 Million | -116.26 Million | -260.11 Million | -369.88 Million | -89.88 Million |
Dividends payments | - | - | -166.17 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 557.6 Million | 557.6 Million | - | - |
Other Financing Activities | -1.88 Million | - | - | - | - | - |
Accounts receivables | -23.25 Million | - | - | - | - | - |
Accounts payables | 35.13 Million | - | - | - | - | - |
Inventory | 3.09 Million | 38.02 Million | 49.42 Million | 22.98 Million | -57.95 Million | 3.06 Million |
Other working capital | -11.15 Million | - | - | - | - | - |
Cash at beginning of period | 387.42 Million | 320.53 Million | 421.91 Million | 347.55 Million | 342 Million | 430.65 Million |
Cash at end of period | 335.91 Million | 387.42 Million | 320.53 Million | 320.53 Million | 347.55 Million | 342 Million |
Capital Expenditure | -113.11 Million | -81.05 Million | -256.29 Million | -58.64 Million | -54.91 Million | -30.86 Million |
Effect of forex changes on cash | 809 Thousand | 1.67 Million | -1.68 Million | -1.92 Million | 2.89 Million | -3.22 Million |
Net cash flow / Change in cash | -51.5 Million | 66.88 Million | -101.38 Million | -27.01 Million | 5.55 Million | -88.65 Million |
Free Cash Flow | -48.4 Million | 2.88 Million | -16.5 Million | 11.67 Million | -80.14 Million | -34.72 Million |
CLX
603192
3104
AVADHSUGAR
ASYS
6566